Suppression of innate immunity by ADP ribosyltransferase type III effectors

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/0611/30/13

Funding

  • National Institutes of Health: $355,714.00
  • National Institutes of Health: $360,106.00
  • National Institutes of Health: $355,544.00
  • National Institutes of Health: $359,475.00
  • National Institutes of Health: $363,270.00
  • National Institutes of Health: $363,430.00

ASJC

  • Medicine(all)
  • Immunology and Microbiology(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.